Sell. The current market price prices in a flawless turnaround, ignoring persistent structural ROE deficits and operational complexity.
Bull: Successful divestitures and cost-cutting initiatives close the ROE gap with peers, leading to a multiple re-rating and consistent double-digit EPS growth, supporting the $116.03 valuation.
Turnaround stagnation: Management fails to execute planned divestitures, leaving ROE below cost of equity indefinitely.
Sell. Citigroup offers an unattractive risk/reward at $130.24. The current valuation embeds turnaround success while ignoring structural ROE deficits, leaving a -33% gap to our $87.05 fair value.
Position sizing playbook →| Market cap | $227.8B | |
|---|---|---|
| Revenue (ttm) | 78.7B | |
| Net income (ttm) | 14.7B | |
| EPS (ttm) | $8.04 | |
| Shares out | 1.7B | |
| P/E (trailing) | 15.6x | |
| P/E (forward) | 10.5x | |
| Dividend | $2.40 (1.91%) | |
| Volume | 17,505,539 | |
| Beta | 1.12 | |
| Price target | $137 | +9.2% |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $71.89B | $74.48B | $78.09B | $80.67B | $85.21B | +4.3% |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $21.95B | $14.85B | $9.23B | $12.68B | $14.31B | -10.2% |
| EPS (diluted) | — | $7.00 | $4.04 | $5.94 | $6.99 | -0.0% |
| EBITDA | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — |
| SG&A | $26.74B | $28.31B | $30.71B | $29.75B | $30.82B | +3.6% |
| Model | Fair value (mid) | Weight |
|---|---|---|
| Forward earnings | $106 | 55% |
| Residual income | $69.18 | 35% |
| Ddm | $44.80 | 10% |
| Reverse DCF | $0.00 | 0% |
| FCFF DCF | $0.00 | 0% |
| Discounted earnings | $190 | 0% |
| Multi stage moat fade | $155 | 0% |
| Owner earnings | $269 | 0% |
| Peg adjusted peer | $27.12 | 0% |
Recent company headlines from major financial publishers.
Successful divestitures and cost-cutting initiatives close the ROE gap with peers, leading to a multiple re-rating and consistent double-digit EPS growth, supporting the $116.03 valuation.
Management executes some simplifications but entrenched complexities keep ROE below cost of capital, anchoring fair value at $87.05 against heavily optimistic internal valuation cross-checks expectations.
Entrenched operational complexities, regulatory hurdles, or a global macro downturn stifle the turnaround, leaving ROE stubbornly low and trapping the stock at a heavily discounted $53.48 valuation.
| Model | Weight | FV / share | vs spot | Contribution |
|---|---|---|---|---|
| Forward earnings | 55% | $106 | -15.5% | |
| Residual income | 35% | $69.2 | -44.9% | |
| Ddm | 10% | $44.8 | -64.3% | |
| Reverse DCF | 0% | $0.00 | -100.0% | |
| FCFF DCF | 0% | $0.00 | -100.0% | |
| Discounted earnings | 0% | $190 | +51.6% | |
| Multi stage moat fade | 0% | $155 | +23.2% | |
| Owner earnings | 0% | $269 | +114.2% | |
| Peg adjusted peer | 0% | $27.1 | -78.4% | |
| Composite FV (weighted) | 100% | $87.0 | -33.2% |
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.7% | $104 | $115 | $129 | $146 | $152 |
| 7.7% | $87.0 | $94.7 | $104 | $115 | $129 |
| 8.7% | $74.9 | $80.5 | $87.0 | $94.7 | $104 |
| 9.7% | $65.8 | $70.0 | $74.9 | $80.5 | $87.0 |
| 10.7% | $58.6 | $62.0 | $65.8 | $70.0 | $74.9 |
| Category | Weight | Score | Reading |
|---|---|---|---|
| Valuation | 11% | 5.0 | |
| Management | 11% | 5.1 | |
| Balance Sheet | 11% | 5.0 | |
| Profitability | 11% | 5.5 | |
| Revenue Growth | 11% | 7.5 | |
| Risk Assessment | 11% | 6.0 | |
| Competitive Moat | 11% | 3.0 | |
| Earnings Quality | 11% | 4.5 | |
| Capital Efficiency | 11% | 4.0 |
Upcoming earnings date and setup when available.